Author:
Ajani J.A.,Abramov M.,Bondarenko I.,Shparyk Y.,Gorbunova V.,Hontsa A.,Otchenash N.,Alsina M.,Lazarev S.,Feliu J.,Elme A.,Esko V.,Abdalla K.,Verma U.,Benedetti F.,Aoyama T.,Mizuguchi H.,Makris L.,Rosati G.
Reference17 articles.
1. Linseisen J, Epidemiology of gastric cancer. Presented at Endo-update 2016; http://www.endoupdate.de/Symposien/Epidemiology%20GC_J.Linseisen_.pdf (18 April 2017, date last accessed).
2. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2008
3. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
4. Gastric cancer: classification, histology and application of molecular pathology;Bing;J Gastrointest Oncol,2012
5. Survival analysis according to disease subtype in AVAGAST: first-line capecitabine and cisplatin plus bevacizumab (bev) or placebo in patients (pts) with advanced gastric cancer;Shah;J Clin Oncol,2012
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献